经皮冠状动脉介入治疗的心肌血运重建：过去、现在和未来。

Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.

出版信息

Curr Probl Cardiol. 2011 Oct;36(10):375-401. doi: 10.1016/j.cpcardiol.2011.05.005.

DOI:10.1016/j.cpcardiol.2011.05.005

Abstract

Percutaneous coronary revascularization was introduced over 30 years ago by Dr Andreas Grüntzig. This event catapulted adult invasive cardiology from a diagnostic entity to a therapeutic modality, which has since become the most frequently performed coronary revascularization procedure worldwide. This success has been built on several key concepts-problem identification, targeted solutions, applied technology, populations-based testing, postmarket surveillance, and education. These concepts will continue to be of paramount importance as novel percutaneous innovations and strategies are brought to bear on an increasingly broader group of patients with cardiovascular disease. In this review, we trace the history, review current practices, and also provide insight into future potential innovations, as it pertains to percutaneous coronary revascularization.

摘要

经皮冠状动脉血运重建术由 Andreas Grüntzig 博士于 30 多年前首创。这一事件将成人介入心脏病学从一个诊断实体推向了治疗模式，自此成为全球最常进行的冠状动脉血运重建术。这一成功基于几个关键概念，包括问题识别、靶向解决方案、应用技术、基于人群的测试、上市后监测和教育。随着新型经皮创新和策略应用于越来越广泛的心血管疾病患者群体，这些概念将继续至关重要。在这篇综述中，我们追溯了经皮冠状动脉血运重建术的历史，回顾了当前的实践，并对未来的潜在创新提供了深入了解。